Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function

Area of Science:

• Gastroenterology and Regenerative Medicine
• Epithelial Biology
• Drug Discovery Models

Background:

• Traditional intestinal epithelial models (cell lines, primary tissues) have significant limitations in representing physiological complexity and availability.
• These limitations hinder fundamental research and drug development processes.

Purpose of the Study:

• To establish and validate intestinal organoid-derived epithelial monolayers as a robust in vitro model system.
• To demonstrate methods for assessing epithelial barrier function, transport, and histology using these organoids.

Main Methods:

• Derivation of intestinal organoids from adult stem cells from various gastrointestinal tract regions.
• Establishment of organoid-derived epithelial monolayers.
• Assessment of epithelial barrier integrity, permeability, transport, and antimicrobial protein secretion.
• Histological analysis of organoid-derived monolayers.

Main Results:

• Successful establishment of intestinal organoid-derived epithelial monolayers.
• Demonstrated ability to measure key epithelial functions including barrier integrity and transport.
• Organoid monolayers can be enriched with specific cell populations, including stem and differentiated cells.
• Organoids accurately reflect in vivo epithelium complexity and interpatient heterogeneity.

Conclusions:

• Intestinal organoid-derived monolayers provide a powerful and versatile model for studying epithelial biology and drug responses.
• This model system overcomes limitations of traditional models, offering improved accuracy and patient-specificity for research and drug development.
• Organoid technology has the potential to reduce late-stage failures in drug development by providing more predictive preclinical data.